AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $575,000 | -16.9% | 7,462 | -9.2% | 0.04% | -35.3% |
Q2 2018 | $692,000 | +13.4% | 8,220 | +10.2% | 0.07% | +38.8% |
Q1 2018 | $610,000 | +42.9% | 7,462 | 0.0% | 0.05% | +32.4% |
Q4 2017 | $427,000 | +113.5% | 7,462 | +149.0% | 0.04% | +68.2% |
Q3 2017 | $200,000 | – | 2,997 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |